References
- Ambekar, A., Parmar, A., Therthani, S., & Mandal, P. (2017). Profile of women substance users seeking treatment at tertiary care treatment center in India. Journal of Substance Use, 22(5), 507–510. https://doi.org/https://doi.org/10.1080/14659891.2016.1255792
- Chand, P., Jayaram, N., & Murthy, P. (2017). Iatrogenic tramadol addiction. Indian Journal of Medical Sciences, 69(1), 57. https://doi.org/https://doi.org/10.18203/.0019-5359.IndianJMedSci20170495
- Cicero, T., Adams, E., Geller, A., Inciardi, J., Muñoz, A., Schnoll, S., Senay, E., & Woody, G. (1999). A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States. Drug and Alcohol Dependence, 57(1), 7–22. https://doi.org/https://doi.org/10.1016/S0376-8716(99)00041-1
- Cicero, T., Inciardi, J., Adams, E., Geller, A., Senay, E., Woody, G., & Muñoz, A. (2005). Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: Results of an abuse monitoring system, 1994–2004. Pharmacoepidemiology and Drug Safety, 14(12), 851–859. https://doi.org/https://doi.org/10.1002/pds.1113
- Dayal, P., & Balhara, Y. (2016). Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India. Indian Journal of Medical Research, 143(1), 95–100. https://doi.org/https://doi.org/10.4103/0971-5916.178616
- Duke, A., Bigelow, G., Lanier, R., & Strain, E. (2011). Discriminative stimulus effects of Tramadol in humans. Journal of Pharmacology and Experimental Therapeutics, 338(1), 255–262. https://doi.org/https://doi.org/10.1124/jpet.111.181131
- Freye, E., & Levy, J. (2000). Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram®): A case study. European Journal of Pain, 4(3), 307–311. https://doi.org/https://doi.org/10.1053/eujp.2000.0187
- Nebhinani, N., Sarkar, S., Gupta, S., Mattoo, S., & Basu, D. (2013). Demographic and clinical profile of substance abusing women seeking treatment at a de-addiction center in north India. Industrial Psychiatry Journal, 22(1), 12–16. https://doi.org/https://doi.org/10.4103/0972-6748.123587
- Prakash, J., & Saini, R. (2010). Tramadol dependence: A case report. Medical Journal Armed Forces India, 66(1), 93–94. https://doi.org/https://doi.org/10.1016/S0377-1237(10)80114-5
- Sarkar, S., Nebhinani, N., Singh, S., Mattoo, S., & Basu, D. (2012). Tramadol dependence: A case series from India. Indian Journal of Psychological Medicine, 34(3), 283. https://doi.org/https://doi.org/10.4103/0253-7176.106038
- Tjäderborn, M., Jönsson, A., Ahlner, J., & Hägg, S. (2009). Tramadol dependence: A survey of spontaneously reported cases in Sweden. Pharmacoepidemiology and Drug Safety, 18(12), 1192–1198. https://doi.org/https://doi.org/10.1002/pds.1838
- Yates, W. R., Nguyen, M. H., & Warnock, J. K. (2001). Tramadol dependence with no history of substance abuse. American Journal of Psychiatry, 158(6), 964. https://doi.org/https://doi.org/10.1176/appi.ajp.158.6.964